Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 15/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HRH1 | P35367 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3310005 | 0.99 | LMNA (0.53) | LMNAMAPTALDH1A1HRH3KCNH2 | |
| SCHEMBL3309995 | 0.91 | HRH3 (0.50) | HRH3KCNH2HRH1 | |
| SCHEMBL3306720 | 0.86 | HRH3 (0.51) | ALDH1A1HRH3KCNH2MEN1KMT2A | |
| SCHEMBL3312305 | 0.85 | HRH3 (0.47) | MAPTHRH3KCNH2HRH1 | |
| SCHEMBL3305550 | 0.85 | HRH3 (0.50) | HRH3KCNH2HRH1 | |
| SCHEMBL3305626 | 0.84 | PARP10 (0.49) | HRH3KCNH2HRH1 | |
| SCHEMBL3312877 | 0.83 | HRH3 (0.50) | HRH3KCNH2HRH1 | |
| SCHEMBL3309315 | 0.82 | MEN1 (0.58) | ALDH1A1HRH3KCNH2MEN1KMT2A | |
| SCHEMBL3313103 | 0.82 | MEN1 (0.55) | ALDH1A1HRH3KCNH2MEN1KMT2A | |
| SCHEMBL3308511 | 0.82 | MEN1 (0.55) | ALDH1A1HRH3KCNH2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100113776-A1 | PYRAZOLE DERIVATIVE | TAISHO PHARMACEUTICAL CO.,LTD. (JP) | 2010-05-06 | — | — | US | claimed |
| US-20100113776-A1 | PYRAZOLE DERIVATIVE | TAISHO PHARMACEUTICAL CO.,LTD. (JP) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113776-A1 | PYRAZOLE DERIVATIVE | HRH3, HRH4, HRH1 | LMNA 4752/4885MAPT 126/4885ALDH1A1 2729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.